Discover how to efficiently characterize biosimilars
High-Tech Solutions to Drug Characterization Challenges
When performing comparability studies on biosimilar drugs, modern instruments simplify the process.
High-Tech Solutions to Drug Characterization Challenges
High-Tech Solutions to Drug Characterization Challenges

When performing comparability studies on biosimilar drugs, modern instruments simplify the process.

When performing comparability studies on biosimilar drugs, modern instruments simplify the process.

drug manufacturing
iStock
A Cleaner Clean Room Starts with the CO2 Incubator
Thermo Fisher Scientific | Aug 15, 2022
Clean room equipment is a leading source of particulate contamination for cell-based biologics manufacturing.
Meet Pharmaceutical Water Quality Standards
Monitoring and Controlling Water Quality for Drug Development
ELGA LabWater | Mar 29, 2022
A detailed look at ensuring water quality compliance for pharmaceutical applications
Prevent Drug Manufacturing Contamination with High Performance Ion Mobility Spectrometry
High Performance Ion Mobility Spectrometry for Cleaning Validation
Excellims | Sep 20, 2021
Discover how this fast, high-resolution analytical technique meets pharmaceutical cleaning validation needs.
rice plants growing in a room with metal walls under artificial light
Rice-based Cholera Vaccine Induces Antibodies in Small Trial
Alejandra Manjarrez | Jul 8, 2021
Immune-response levels to the edible vaccine varied among the subjects, possibly due to differences in the gut microbiome.
Detecting Subvisible Particles in Protein Therapeutics
The Scientist Creative Services Team in collaboration with Yokogawa Fluid Imaging Technologies | Feb 16, 2021
New flow imaging microscopy technology visualizes a broad range of subvisible particles hidden in therapeutic suspensions.  
Accelerating Discovery in the Age of a Pandemic
The Scientist Creative Services Team | Jan 22, 2021
An expert panel will present how synthetic biology accelerates the development of diagnostics, therapeutics, and the medicinal pipeline.
The Scientist Speaks Podcast - Episode 9
The Scientist Creative Services Team | Sep 29, 2020
Repurposing Living Systems to Fight a Pandemic
viral contamination chinese hamster ovary cell line cell culture biomanufacturing pharmaceutical genzyme
Consortium Identifies Risks of Viral Contamination in Biopharma
Emma Yasinski | Apr 27, 2020
Nine of the 20 pharma companies that participated in a study had experienced at least one viral contamination event between 1985 and 2018.
UCB Cuts $2.1 Billion Deal to Acquire Ra Pharma
Catherine Offord | Oct 14, 2019
The move will allow the Belgium-headquartered biopharmaceutical giant to boost its work on treatments for rare diseases.
World’s Largest Cell and Gene Therapy Plant Opens
Catherine Offord | Apr 10, 2018
Lonza will employ more than 200 full-time staff to work at the Texas-based facility, the company says.
Puerto Rico’s Hurricane Damage May Mean Drug Shortages
Ashley P. Taylor | Oct 11, 2017
Three weeks after Hurricane Maria hit the island, pharmaceutical plants are not back up to speed.
Daraprim Discounts Offered
Karen Zusi | Nov 26, 2015
Turing Pharmaceuticals will soon offer discounts to hospitals for its toxoplasmosis-fighting drug, the company announced, but some say the proposed price reductions are not enough.
Novartis Linked to Retracted Papers?
Dan Cossins | Apr 2, 2013
A Japanese newspaper claims that the pharma giant funded flawed research that revealed extra health benefits for one of its top-selling drugs.
Regulations for Biosimilars
Lisa A. Haile and Kimberly K. Egan | Jun 1, 2012
As biologic drug patents begin to expire, generic versions will hit the market—but how will they be regulated?
Bogus Isomer Vendors Identified
Sabrina Richards | May 25, 2012
Pharma company publishes a list of 17 companies known to have sold the incorrect isomer of the kinase inhibitor bosutinib.
Mismarketed Chemical Causes Concern
Sabrina Richards | May 13, 2012
An incorrect isomer of the kinase inhibitor bosutinib is circulating in the biomedical research community, potentially throwing doubt on study results.
A Bill to Expedite Drug Production
Jef Akst | Feb 2, 2012
Legislation proposes speeding certain drug applications submitted to the US Food and Drug Administration.